Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-18

Clinical Trial Update: Serum-Derived Bovine Immunoglobulin /Protein Isolate (SBI) 5.0 g Bid on Nutritional Status in Subjects With IBS-D [NA]

View source ↗

Summary

This clinical trial update reports completion of a study evaluating Serum-Derived Bovine Immunoglobulin/Protein Isolate (SBI) 5.0 g twice daily on nutritional s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Serum-derived bovine immunoglobulin protein isolate (serum-derived bovine immunoglobulin protein isolate)

Snippet

Sponsor: Mayo Clinic | Conditions: Diarrhea-predominant Irritable Bowel Syndrome | NA | Status: COMPLETED